Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

HIV hotline

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
HIV Hotline|May 22, 2001
Breaking zinc fingers
HIV Hotline|May 22, 2001
CCR5 mutations and HIV susceptibility
HIV Hotline|May 22, 2001
Do ultrasensitive assays have clinical value?
HIV Hotline|May 22, 2001
Choosing NRTI combinations
HIV Hotline|May 22, 2001
Improved treatment results with interleukin-2
HIV Hotline|May 22, 2001
The thalidomide comeback
HIV Hotline|May 22, 2001
Dual protease inhibitor therapy
HIV Hotline|May 22, 2001
The quality factor
HIV Hotline|May 22, 2001
Does the choice of alpha-AAS really make a difference?C Mutzebaugh
HIV Hotline|May 22, 2001
More IDSA '98 highlights
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
HIV Hotline|May 22, 2001
Breaking zinc fingers
HIV Hotline|May 22, 2001
CCR5 mutations and HIV susceptibility
HIV Hotline|May 22, 2001
Do ultrasensitive assays have clinical value?
HIV Hotline|May 22, 2001
Choosing NRTI combinations
HIV Hotline|May 22, 2001
Improved treatment results with interleukin-2
HIV Hotline|May 22, 2001
The thalidomide comeback
HIV Hotline|May 22, 2001
Dual protease inhibitor therapy
HIV Hotline|May 22, 2001
The quality factor
HIV Hotline|May 22, 2001
Does the choice of alpha-AAS really make a difference?C Mutzebaugh
HIV Hotline|May 22, 2001
More IDSA '98 highlights
Pageof 2